Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Rodenstock spectacle lenses to slow myopia progression in children

Official title: Testing the Efficacy of Rodenstock Spectacle Lenses in Myopia Progression: a Two Year Clinical Trial

Run by Rodenstock GmbH · NCT06816446 · Data updated 2026-11-12

This will test whether Rodenstock myopia-control spectacle lenses can slow myopia progression in children aged 6–12 over two years.

More Myopia trials

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment185 (estimated)
SponsorRodenstock GmbH
Industry-sponsored
Locations1 site (Singapore)
StatusRecruiting
StartedJuly 22, 2025
Main results expectedDecember 2026
Study endsDecember 2027
Registry record updatedSeptember 16, 2025
Trial IDNCT06816446 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are treatment-naïve children aged 6–12 with myopia between −0.5 D and −5.0 D, anisometropia ≤1.5 D, corneal astigmatism ≤1.5 D, and good best-corrected visual acuity.

Probably not a fit

Children already using myopia-control treatments, those with other diagnosed ocular or systemic conditions, irregular or high astigmatism, or contraindications to cycloplegia are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Children who meet the eligibility criteria will be assigned to wear either Rodenstock myopia-control spectacle lenses or standard single-vision lenses and followed for 24 months. Regular eye examinations, including cycloplegic refraction and axial length measurements, will track changes in prescription and eye growth. The trial enrolls treatment-naïve myopic children with spherical equivalent between −0.5 D and −5.0 D and limits astigmatism and anisometropia to specified ranges. Safety, tolerability, and change in myopia progression will be compared between the lens groups.

Why it matters

Potential benefit: If successful, these lenses could slow myopia progression in school-age children and lower the long-term risk of high-myopia complications.

How similar studies have gone: Other optical approaches such as multifocal contact lenses, orthokeratology, and some specially designed spectacle lenses have shown moderate success in slowing myopia, although results vary by design and population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All myopic children aged 6-12 years old
* Treatment naïve
* Sphere: -0.5 D till -5.00 D
* Anisometropia \< 1.5D
* Astigmatism \> -1.5D
* Monocular best corrected visual acuity +0.1 logMAR or better, and binocular visual acuity 0.0 logMAR or better

Exclusion Criteria:

* On current myopia control treatments
* Any diagnosed ocular conditions besides myopia or astigmatism.
* No diagnosed ocularmotor conditions (Nystagmus, strabismus, etc.)
* Any diagnosed chronic physical or mental disabilities
* Contraindication in cycloplegia (high IOP, etc.)
* Corneal astigmatism \> 1.5 D; irregular astigmatism

Where it's running

  • Nuh
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.